Wrapmanager Inc Abb Vie Inc. Transaction History

Wrapmanager Inc

$382 Million
Q3 2024

A detailed history of Wrapmanager Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wrapmanager Inc holds 12,120 shares of ABBV stock, worth $2.13 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

12,120

Previous 12,024 0.8%

Holding current value

$2.13 Million

Previous $2.06 Million 16.05%

% of portfolio

0.63%

Previous 0.58%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$163.84 - $199.33 $15,728 - $19,135	96 Added 0.8%	12,120 $2.39 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $57,891 - $67,604	374 Added 3.21%	12,024 $2.06 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $2,557 - $2,913	-16 Reduced 0.14%	11,650 $2.12 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $45,545 - $51,295	331 Added 2.92%	11,666 $1.81 Million
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $34,065 - $39,435	255 Added 2.3%	11,335 $1.69 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $180,876 - $225,088	-1,365 Reduced 10.97%	11,080 $1.49 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $1,446 - $1,665	10 Added 0.08%	12,445 $1.98 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $60,026 - $71,987	434 Added 3.62%	12,435 $2.01 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $8,589 - $9,851	-64 Reduced 0.53%	12,001 $1.61 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $396,345 - $503,884	-2,880 Reduced 19.27%	12,065 $1.85 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $276,366 - $342,892	-2,094 Reduced 12.29%	14,945 $2.42 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $14,825 - $18,758	-138 Reduced 0.8%	17,039 $2.31 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $41,176 - $46,741	-387 Reduced 2.2%	17,177 $1.85 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $29,564 - $32,936	281 Added 1.63%	17,564 $1.98 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $227,208 - $250,129	-2,221 Reduced 11.39%	17,283 $1.87 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $140,294 - $189,411	-1,743 Reduced 8.2%	19,504 $2.09 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $134,620 - $158,000	-1,567 Reduced 6.87%	21,247 $1.86 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $44,535 - $59,595	607 Added 2.73%	22,814 $2.24 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $322,629 - $489,145	5,002 Added 29.07%	22,207 $1.69 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $254,618 - $318,582	-3,530 Reduced 17.02%	17,205 $1.52 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $106,877 - $128,496	1,697 Added 8.91%	20,735 $1.57 Million
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $33,507 - $42,829	-510 Reduced 2.61%	19,038 $1.38 Million
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $214,912 - $252,940	2,786 Added 16.62%	19,548 $1.58 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $667,719 - $823,477	8,577 Added 104.79%	16,762 $1.55 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $243,791 - $271,019	2,742 Added 50.38%	8,185 $774,000
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $108,274 - $128,113	-1,206 Reduced 18.14%	5,443 $504,000
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $829,838 - $1.11 Million	-9,019 Reduced 57.56%	6,649 $629,000
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $1.02 Million - $1.12 Million	-11,407 Reduced 42.13%	15,668 $1.52 Million
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $1.89 Million - $2.42 Million	27,075	27,075 $2.41 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.

Account